niphimycin analogs, amycins A (5) and B (3) . Niphimycin (4) was isolated first from Streptomyces hygroscopicus B-255 in 196712). The structure was elucidated in 198313 '14) . Furthermore, it could be proved that scopafungin, which was first isolated 1971 from S. hygroscopicus var. enhygrus15'i6\ is identical with niphimycin (4)17~19). Closely related to niphimycin (4) are the azalomycins F3, F4 and F520'21), copiamycin, neocopiamycin22 '23) and guanidylfungins A and B24'25). All antibiotics mentioned are active against
Gram-positive bacteria and fungi26'27). Compound4 is an inhibitor of the oxidative phosphorylation in mitochondria1 9).
Characterization of the Producing Strains The producing strains DSM3816 and DSM4137 belong to the genus Streptomyces. The strain DSM 3816 was isolated from a soil sample from Kypcerissia, Greece and the strain DSM4137 was a laboratory isolate. The strains are characterized as follows in Table 1 .
Fermentation and Isolation
The metabolite pattern and the yields of the different antibiotics is dependent on the culture medium f This paper is dedicated to Professor Dr. Wolf gang Hilger on the occasion of his 60th birthday.
tf Seerefl. as well as on the culture conditions. For production of the antibiotics nigericin (1), elaiophylin (2), niphimycin (4) and the amycins A (5) and B (3) in a 200-liter Braun fermenter, we used the strain DSM 3816 with a mediumcontaining soybean meal 2%and mannitol 2%. The production of the antibiotics during the fermentation was followed by TLC. After incubation for 120 hours at 30°C the amount of the antibiotics has reached its maximum and the culture was harvested. From both strains the metabolites could be isolated easily (Fig. 2 ). The mycelium (1.8 kg) of DSM 3816 was separated from the culture filtrate by centrifugation. After drying it was extracted with 3 x 15 The work up procedure of DSM4137 was carried out as described for DSM3816. Extraction with hexane removes some non-polar impurities which would disturb the crystallization process of elaiophylin from ethyl acetate. Niphimycin was also extracted with methanol and chromatographed with HPLCon RP-C-18 with the same solvent system.
Structure Elucidation
Nigericin (1)6), elaiophylin (2)11} and niphimycin (4)14), were identified by comparison of the NMR spectra with data given as reference.
The amycins have Rfvalues on TLCsilica gel in the solvent system acetic acid -butanol -water (1 : 4 : 5) similar to niphimycin (4). Furthermore they show identical color reactions with anisaldehyde -sulforic acid exhibiting a blue colored spot. Compounds2 and 5 were only soluble in lower alcohols, e.g., methanol, ethanol, butanol. The UVspectra (Amax 231 nm) were in all these compounds almost identical. It can be assumed that these compoundsare niphimycin analogs. This can be verified by comparison of the FAB mass spectra of3 and 5 ( Fig. 3 ). Amycin A (5) exhibits a molecular ion at m/z 1,229 (M+H)+ and amycin units. This difference might be explained by a malonyl residue. It can be assumed that amycin B (3) contains a malonyl-monoester less and amycin A (5) has one more than niphimycin. This has been proved by the 13C NMRspectra of3, 4 and 5 (Fig. 4) . The 13C NMRspectrum of niphimycin (4) shows the signals ofC-l at S 176.8 and of the malonyl group at d 168.9 (-COOR) and S 170.9 (COOH). In the 13C NMRspectrum of amycin B (3) no signals of the malonyl moiety can be detected. Amycin A (5) exhibits two signal groups of the malonyl group at S 169.1 and 168.8 (COOR) and S 171.0 and 170.6 (COOH).
It was not possible to completely assign the signals in the 13C NMR spectra as well as the position of the second malonyl group in 5. This was due to the overlay of signal groups in the 2D-NMRcontour plots.
The malonyl-monoester groups of 5 could be hydrolyzed. Problems arise from the base sensitivity of these compounds, especially in the retro aldol-cleavage in position C-15/C-17 or C-19/C-17. So the saponification of 4 is described only by prior ketalization at C-1728~30). This was avoided by controlled reaction conditions with sodium methoxide in methanol at 0°C. Amycin A (5) was dissolved in methanol and kept in solution for 10 days at room temperature yielding niphimycin (4). Whenamycin A (5) or niphimycin (4) was treated with sodium methoxide in methanol for 12 hours amycin B (3) was obtained in 80% yield. The ketalization of 3 to 6 with acidic methanol was carried out as described28~30).
Biological Activities
Niphimycin is active against Gram-positive bacteria and fungi (Table 2 ). (The reaction sequence 5->4->3 without ketalization had an advantage concerning the biological activity).
The demalonyl derivatives of methyl-copiamycin, methyl-guanidylfungin A and methyl-azalomycin F4 showed higher activity against bacteria and fungi than the parent compounds28~30). Because of the /Miydroxy-keto moiety in all molecules, where a retro aldol-cleavage is possible, a protection has to take place before the saponification. These derivatives exhibit a decreased antifungal activity, which could be increased by saponification of the malonyl-monoester group. It can be assumedthat the demalonyl compoundswithout the ketal group show the highest activities against fungi. The demalonyl product amycin B (3) which is now available by fermentation as well as by chemical degradation of 4 and 5, had an increased activity against bacteria compared with amycin A (5) and niphimycin (4) . The ketalization to 6 leads to a decreased activity against bacteria and fungi.
Discussion
Amycins A (5) and B (3) are two novel niphimycin analogs. Because of instability of the additional malonyl-monoester in 5 against nucleophiles in comparison with niphimycin (4), it can be assumed that the dimalonyl compound 5 is the original fermentation product. Niphimycin (4) and amycin B (3) are hydrolyzed products of 5, which were generated by nucleophiles in the fermentation broth. Another natural product, which was described without a monoester group, is demalonylcopiamycin28).
It was shownthat the cleavage of the monoester in 5 to 4 and 3 leads to higher activities against bacteria, fungi and yeast. Niphimycin (4) exhibited the highest activity against fungi and amycin B (3) showed the highest antibacterial activity.
Experimental General IR spectra in pressed KBrdisks were recorded on a Perkin-Elmer 197 spectrometer, UVspectra using a Perkin-Elmer 550 S UVVis spectrophotometer. The NMRspectra were determined with a Bruker AM-300. Chemical shifts are expressed in values (ppm) with TMSas an internal standard. The FABmass spectra were taken by a MS50 Kratos Analytical (FAB-MS) with 3-nitrobenzyl alcohol as matrix.
TLCwas carried out on Silica gel plates (Merck 60 F254). HPLCwas performed with a Waters M 6000 with a RP-C-18 (Merck) column.
Antifungal Testing
The test was performed as a serial dilution in the test tube. A predetermined concentration of the test compound was dissolved in a suitable solvent (e.g. DMSO) (12.5mg compound + l ml organic solvent +9ml distilled water or 12.5mg compound +10ml distilled water). The media (cutaneous fungi:
Neopeptone -glucose broth; yeasts and moulds: Yeast -nitrogen base) were mixed with benzylpenicillin sodium and streptomycin sulfate (200 IU/liter each) to prevent bacterial growth, in the routine screening. The starting tubes (cutaneous fungi: 2~24 tubes/strain; yeasts and moulds: 12 tubes/strain) are each filled with 5.4ml medium, 0.6ml compoundsolution was added to each, mixed and diluted in the ratio of 1 : 2 by transferring 3ml from each tube into the following tube containing 3ml.
Each tube was then inoculated with 1 drop of standardized organism suspension (=160,000
micro-conidia/ml (cutaneous fungi)) or 1,000 conidia or cells/ml (yeasts and moulds).
There was also a growth control (inoculated, not medicated), a solvent control (inoculated, not medicated, containing solvent as in medicated tubes) and a negative control (not inoculated, not medicated, containing only medium). For compound3 the antifungal tests were performed under the same conditions, without the antibiotics mentionedabove, to verify that no synergism was observed in the routine test.
After incubation for 10 days at 30°C, the tubes were inspected macroscopically for growth.
Antibacterial Testing
The sensitivity of bacteria was tested by means of the agar dilution test in Mueller-Hinton agar (Difco). When testing Streptococci, the agar was supplemented with 10% horse blood. Plates were inoculated with a Denley Multipoint inoculator which delivered 5 x 104cfu of an overnight culture of the strain concerned. The MICwas taken as the lowest concentration at which no visible growth could be detected after 24 hours at 37°C. The MIC50was calculated from the results. If 1 g was chromatographed and the solvent evaporated and dried in oil pump vacuum for 2 hours 250mg amycin A (5), 175mg niphimycin (4) and 6mg amycin B (3) was obtained as white foams. Cleavage of the Malonyl Moiety; Amycin B (3) from 5 1 g amycin A (5) was stirred in 100ml MeOHwith 100mg NaH for 12 hours at 0°C. After neutralization with 5 n HC1, the solvent was removed by evaporation in vacuo. The resulting syrup was purified by HPLC (RP-C-18 column) with MeOH-water (8 : 2). Evaporation of the solvent in vacuo yielded 680mg (70%) amycin B (3 Amycin B from 4 1 g niphimycin (4) was stirred in 100ml methanol for 12 hours at 0°C in the presence of lOOmgNaH. The work up procedure was carried out as described for amycin B.
Methylamycin B (6)30) 1 g ofamycin B was stirred with a mixture of 1.5ml ofacetyl chloride and 75ml of methanol at room temperature for 15 minutes. After neutralization with 5 n NaOH,the mixture is concentrated in vacuo to a syrup. Chromatography by HPLCon RP-C-18 with MeOH-water (8 : 2) yields after evaporation of the solvent 800mg (78%) 6.
